Sinopharm Group
Sinopharm Group Co. Ltd. is a major Chinese pharmaceutical and healthcare products distribution enterprise operating under state supervision. The company provides a comprehensive range of supply chain services, including wholesale distribution of medicines, medical devices, laboratory supplies, and retail pharmacy operations. Its primary revenue drivers consist of large-scale pharmaceutical distribution contracts with hospitals, clinics, and regional distributors across domestic markets. Operating on a vast national scale, the firm commands a dominant position as the leading pharmaceutical distributor and healthcare supply chain provider in China. The company is headquartered in Shanghai, China, and its shares are publicly listed on the Hong Kong Stock Exchange. Through an extensive distribution network and strict regulatory compliance, the enterprise maintains a foundational role in the healthcare delivery infrastructure of the country.
22 of the funds FundTelligence covers report a position in Sinopharm Group.
- Legal name
- SINOPHARM GROUP CO
- Sector
- Health Care
- Country
- China
- Funds holding it
- 22
Funds holding Sinopharm Group
- Sparinvest Ethical Emerging Markets Value — Sparinvest · 0.73 % (full portfolio disclosed, September 2026)
- Nordea Stable Emerging Markets — Nordea Funds · 0.48 % (full portfolio disclosed, July 2026)
- KLP AksjeFremvoksende Markeder Flerfaktor — KLP · 0.38 % (full portfolio disclosed, June 2026)
- SEB Emerging Marketsfond — SEB · 0.17 % (full portfolio disclosed, June 2026)
- Nordea Emerging Markets — Nordea Funds · 0.11 % (full portfolio disclosed, September 2026)
- Nordea Emerging Market Equities — Nordea Funds · 0.11 % (full portfolio disclosed, September 2026)
- Storebrand Emerging Markets Plus — Storebrand · 0.1 % (full portfolio disclosed, October 2026)
- Storebrand Emerging Markets — Storebrand · 0.09 % (full portfolio disclosed, October 2026)
Showing the 8 largest of 22 funds holding it.